Rituximab Injection

Approval Id: 1z9BRZ8LdoC
Approval Number: 国药准字S20230033
Generic Name: 利妥昔单抗注射液
Generic Name En: Rituximab Injection
Trade Name: 得利妥
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 100mg（10ml）/瓶
Reg Date: 2023-05-26
Company Name: 正大天晴药业集团南京顺欣制药有限公司
Company Address: 南京市江宁区福英路1099号（江宁高新园）
Production Company Name: 正大天晴药业集团南京顺欣制药有限公司
Production Company Address: 南京市江宁区福英路1099号（江宁高新园）
Company Detail Path: /organization/zheng-da-tian-qing-yao-ye-ji-tuan-nan-jing-shun-xin-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/zheng-da-tian-qing-yao-ye-ji-tuan-nan-jing-shun-xin-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

May 26, 2023

Approval ID

1z9BRZ8LdoC

Type

生物制品